Harvard Bioscience Inc. Reports Q2 2026 Earnings; Schedules Call

What Happened

• Harvard Bioscience, Inc. filed Form 8-K on August 11, 2026 to announce its financial results for the three and six months ended June 30, 2026. The company issued a press release reporting those results and provided details for a related conference call.
• The press release was furnished as Exhibit 99.1 to the filing. Management’s conference call was scheduled for 8:00 AM ET on August 11, 2026.

Key Details

• Filing date: August 11, 2026.
• Reporting periods: three and six months ended June 30, 2026 (Q2 2026).
• Conference call: scheduled for 8:00 AM ET on August 11, 2026.
• Press release is included in the filing as Exhibit 99.1.

Why It Matters

• The press release and conference call are the company’s primary sources for the quarter’s earnings, revenue and operating performance; investors should review Exhibit 99.1 or listen to the call for the specific financial figures and management commentary.
• These disclosures provide updated information on Harvard Bioscience’s recent operating results and near-term outlook, which can affect investor assessments of the company’s revenue and profitability trends.